Innospark is an early-stage venture capital firm supporting founders who put data science and AI to work solving hard problems in life sciences, healthcare, and vertical enterprise.

Nucleate Bio is an entrepreneurship organization enabling the formation of life science ventures. The Boston-born initiative counts more than 100 alumni teams that have gone on to raise more than $300M in outside funding, and operates in cities across the US and around the world.

Carmine is a biotechnology company developing novel non-viral gene therapies leveraging the properties of red blood cell extracellular vesicles.

The Center for External Innovation sources, transacts and supports external ideas for creating new therapeutic options in Takeda’s areas of focus. The CEI oversees all R&D business development, venture investments, academic alliances, and externalizations, and supports M&A efforts as well.

Binney Street Capital is Dana-Farber’s first-ever venture fund, capitalizing on investment opportunities created by Dana-Farber innovations and investigators.

Lifespan Equity Partners is a private equity firm that invests in healthcare service and technology businesses that improve quality of care.

Trinity is a life sciences consultancy integrating research, analytics, and technology to better advise the commercialization of new interventions improving human health.